Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-06

Clinical Trial Update: Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating the effects of ramipril and clopidogrel on oxidative stress, vascular inflammation, and endothelial dysfunction in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)
  • Ramipril (ramipril)

Snippet

Sponsor: AHEPA University Hospital | Conditions: Diabetes Type 2, Diabetic Nephropathy | Phase 4 | Status: UNKNOWN